Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Trifluoroacetic acid | HCID 6422 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | Trifluoroacetamide | HCID 67717 | — |
| Reactant | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| Reactant | 4-(1,2,3-Thiadiazol-4-yl)benzoic acid | HCID 2776451 | — |
| Reactant | HCID 86667237 | HCID 86667237 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Methanol--water (1/1) | HCID 22242641 | — |
| Product | Benzamide | HCID 2331 | 48% |
Reaction Steps
Stir a solution of 4-[1,2,3]thiadiazol-4-yl-benzoic acid (21 mg, 0.10 mmol) and CDI (19 mg, 0.11 mmol) in DMF (3 mL) at rt for 1.5 h. To the clear solution add 3-aminomethyl-N—[(S)-6-(2,2,2-trifluoro-acetylamino)-4,5,6,7-tetrahydro-benzothiazol-2-yl]-benzamide hydrochloride (45 mg, 0.10 mmol) followed by Et3N (0.098 mL, 0.70 mmol). Stir the mixture at rt overnight. Concentrate and use the mixture in the next step without any purification. Dissolve the crude trifluoroacetamide (50 mg, 0.085 mmol) in 4:1 MeOH/H2O (10 mL). Add potassium carbonate (47 mg, 0.34 mmol) to the mixture and stir at 50° C. for 48 h. Add a small amount of TFA to the mixture and purify by prep-HPLC (10% to 100%, CH3CN/H2O) to give the desired product N—((S)-6-amino-4,5,6,7-tetrahydro-benzothiazol-2-yl)-3-(4-[1,2,3]thiadiazol-4-yl)-aminomethyl)-benzamide in 48% yield (20 mg, 0.041 mmol) MS, electrospray 491.1 (M+H), rt 0.55 min.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08697911B2 |
|---|
| Source dataset | uspto-grants-2014_04 |
|---|
| ORD ID | ord-89ab6d4bec744199b5d4a66b617db814 |
|---|
| Source note | uspto-grants-2014_04 |
|---|